<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The past decade has witnessed a growing frequency of therapy-related <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">secondary tumors</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The authors studied nine children with <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">secondary malignancies</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> were bilateral <z:hpo ids='HP_0009919'>retinoblastoma</z:hpo>, <z:hpo ids='HP_0003006'>neuroblastoma</z:hpo>, <z:mp ids='MP_0009277'>brain tumor</z:mp>, <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumor</z:e>, <z:mp ids='MP_0009314'>colon adenocarcinoma</z:mp>, and <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">secondary tumors</z:e> were <z:hpo ids='HP_0002669'>osteosarcoma</z:hpo> at the site of previous radiotherapy, <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, <z:hpo ids='HP_0004808'>acute myelocytic leukemia</z:hpo>, <z:hpo ids='HP_0100843'>glioblastoma</z:hpo>, <z:hpo ids='HP_0002890'>thyroid carcinoma</z:hpo>, and B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: DNA was extracted from the primary and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">secondary tumors</z:e> and analyzed for genetic alterations in the p53 gene and in 7 separate microsatellites </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The authors found p53 mutations in 7 patients, loss of heterozygosity in 1 patient, and both mutation and loss of heterozygosity in 1 patient </plain></SENT>
<SENT sid="6" pm="."><plain>Mutations were demonstrated in the <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> only in two patients and in the <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">secondary tumors</z:e> only in three patients </plain></SENT>
<SENT sid="7" pm="."><plain>Two patients had a mutation in both the primary and the <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">secondary tumor</z:e>; in both patients the two mutations were in different exons </plain></SENT>
<SENT sid="8" pm="."><plain>Microsatellite instability (MIN) was identified in five to seven loci in the <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">secondary tumors</z:e> of <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: The observed MIN is compatible with the presence of a mutator phenotype that predisposes these children to the development of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">secondary malignancies</z:e> </plain></SENT>
</text></document>